Results 61 to 70 of about 30,645 (194)

Functionally cured chronic hepatitis B: A cure‐related occult HBV infection state

open access: yesmLife, Volume 5, Issue 4, Page 393-400, August 2026.
Abstract Occult HBV infection (OBI) is characterized by the presence of replication‐competent hepatitis B virus (HBV) DNA (covalently closed circular DNA [cccDNA] and/or relaxed circular DNA [rcDNA]) in the liver and/or HBV DNA in the blood, despite negative hepatitis B surface antigen (HBsAg) serology.
Fengmin Lu   +6 more
wiley   +1 more source

Forest Plot for HBeAg Seroconversion when ETV was used as the Control Group.

open access: yes, 2015
Forest Plot for HBeAg Seroconversion when ETV was used as the Control Group.
Qiao-Ling Xie (777501)   +4 more
core   +1 more source

TCRγδ(+)CD4(-)CD8(-) T cells suppress the CD8(+) T-cell response to hepatitis B virus peptides, and are associated with viral control in chronic hepatitis B. [PDF]

open access: yesPLoS ONE, 2014
The immune mechanisms underlying failure to achieve hepatitis B e antigen (HBeAg) seroconversion associated with viral control in chronic hepatitis B (CHB) remain unclear.
Qintao Lai   +11 more
doaj   +1 more source

Temporal Association Between COVID‐19 Vaccination and HBsAg Loss in Chronic Hepatitis B Infection: An Interrupted Time Series Analysis

open access: yesAlimentary Pharmacology &Therapeutics, Volume 64, Issue 4, Page 517-526, August 2026.
In 59,946 chronic hepatitis B patients followed over 23 years, COVID‐19 vaccination rollout was temporally associated with a 56% increase in HBsAg loss rates (peak 1.27 per 100 person‐years in 2022), followed by gradual waning. Negative control outcomes showed no similar pattern, supporting biological specificity. ABSTRACT Background and Aims Hepatitis
Jonggi Choi   +6 more
wiley   +1 more source

Vaccination Coverage and Prevention Counselling for Vaccine‐Preventable STIs Among HIV PrEP Users in São Paulo, Brazil: A Retrospective Cohort Study

open access: yesJournal of the International AIDS Society, Volume 29, Issue S2, July 2026.
ABSTRACT Introduction HIV pre‐exposure prophylaxis (PrEP) users may be disproportionately vulnerable to sexually transmitted infections (STIs) in general, including several that are vaccine‐preventable. Understanding immunization patterns in this population is, therefore, crucial. However, data on vaccination coverage among Brazilian PrEP users remains
Marjorie Marini Rapozo   +6 more
wiley   +1 more source

Odds ratios of HBeAg seroconversion after 2-year treatment as revealed by network meta-analysis.

open access: yes, 2017
Odds ratios of HBeAg seroconversion after 2-year treatment as revealed by network meta-analysis.
Lin Cao (294505)   +3 more
core   +1 more source

Treatment of Chronic Hepatitis B with Interferon: Long Term Follow-Up

open access: yesCanadian Journal of Gastroenterology, 1996
The aim of treatment of chronic hepatitis B with interferon is to induce a transition from the replicative phase of the disease to a nonreplicative state, with loss of hepatitis B virus (HBV)-DNA, seroconversion from hepatitis B e antigen (HBeAg ...
Jean-Pierre Villeneuve, Bernard Willems
doaj   +1 more source

Evolving Strategies in HBV Management: Insights From Updated International Guidelines

open access: yesHepatology Research, Volume 56, Issue 7, Page 1070-1078, July 2026.
Recent updates to WHO (2024), EASL (2025), and AASLD (2025) hepatitis B guidelines reflect divergent strategies, ranging from simplified public health‐oriented treatment expansion to biomarker‐driven precision medicine. Despite differences in treatment eligibility and nucleos(t)ide analogue discontinuation, all guidelines converge on early intervention
Masaru Enomoto   +3 more
wiley   +1 more source

Cumulative HBeAg seroconversion rates in survivors of infantile fulminant/non-fulminant hepatitis B (N = 9).

open access: yes, 2014
Cumulative HBeAg seroconversion rates in survivors of infantile fulminant/non-fulminant hepatitis B (N = 9).
Fu-Chang Hu (177537)   +11 more
core   +1 more source

Incidence and Characteristics of HBV Reactivation‐Related Events Following HBsAg Seroclearance: Long‐Term Follow‐up of a Population‐Based Cohort in Japan

open access: yesHepatology Research, Volume 56, Issue 6, Page 944-955, June 2026.
In a population‐based cohort in Japan, HBV reactivation‐related events were observed after HBsAg seroclearance, including one virologically confirmed hepatic flare occurring spontaneously without chemotherapy or immunosuppression. These findings indicate that HBsAg seroclearance does not always represent complete viral eradication, supporting the need ...
Kazumi Yamasaki   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy